PLASMA PROTEIN THERAPEUTICS ASSOCIATION for PLASMA PROTEIN THERAPEUTICS ASSOCIATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. Educational meetings describing the plasma protein industry, and economic value, in the House and Senate. The proposed rule on International Pricing Index and Competitive Acquisition Program as well as Reference pricing and step therapy.
Foreign entity interest: GRIFOLS S.A.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE BIRKOFER | — |
| AMY CHEVALIER EFANTIS New | Legislative Director, Rep. Artur Davis; Legislative Assistant, Rep. Tom Barrett |
| THOMAS B LILBURN | — |
| BRENNA RAINES | — |
| KIMBERLY SEROTA | — |
| CHASE THOMAS | — |
Medicare/Medicaid MMM
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R.4724 - Medicare IVIG Access Enhancement Act - provisions relating to the development and funding for a IVIG demonstration project. HHS "American Patients First" request for information relating to Part B programs, essential health benefits, competitive acquisition programs and 340B discount programs. Part B to D issues. Issues and comments related to CMS-5528-ANPRM and HHS proposed rule :Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees
Foreign entity interest: GRIFOLS S.A.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE BIRKOFER | — |
| AMY CHEVALIER EFANTIS New | Legislative Director, Rep. Artur Davis; Legislative Assistant, Rep. Tom Barrett |
| THOMAS B LILBURN | — |
| BRENNA RAINES | — |
| KIMBERLY SEROTA | — |
| CHASE THOMAS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.